
IOVAIovance Biotherapeutics, Inc. Common Stock
IOVA Options Overview
Mixed signals. No clear edge detected.
REWARDS
RISK ANALYSIS
IOVA Gamma Walls
Value
Is IV priced right?
Measures whether options are cheap, fair, or rich relative to historical and peer
IV Rank 50.0% — elevated vs history
IV/HV 1.00x — IV ≤ HV
Sector percentile 50% — below sector median
Front/Back 0.95x — contango
Put/Call IV 1.00x — normal
ATM IV 0.0% — normal range
Effective IV 49.5% (ATM 0.0% + spread 24.8% + bias) — excellent value
Total drag 29.18% (spread 24.75% + slippage 4.43%) — high friction
Vega efficiency 0.00 (vega 0.000 / spread 24.75%) — spread drag
Sentiment
Bullish or bearish?
Analyzes
Conviction-weighted: +10% (neutral) — Raw: +16%
|OI skew| 37.9% — call-heavy
Vol skew -11.1%, OI skew +37.9% — divergent (opposite)
0-DTE 17%, far-OTM 15%, avg DTE 30
OI change +0.0% (5d) — stable
ITM: -29%, ATM: -55%, OTM: +29% — strong bearish (ITM/ATM aligned)
Sector P/C percentile 80% — very bearish vs sector
Activity
Unusual activity?
Detects volume surges,
Volume 0.4x avg — normal
Vol/OI 2.3% — normal turnover
1 day(s) elevated — may be one-day event
OI change +3.3% (5d) — building
Sector activity percentile 59% — neutral vs sector
Large trade volume 53% — heavy institutional
Aggressive execution 17% — patient
Conviction +10 (bullish) — mixed
Liquidity
Can I trade efficiently?
Evaluates
Spread 24.8% — wide
OI 340,085 — deep
Volume 7,876/day — active
$1.24 to cross — expensive
0 liquid strikes — limited options
Sector spread percentile 0% — much tighter than sector
Depth 480.5 contracts (bid:292.5 ask:188.0) — adequate
Avg slippage 4.43% — poor
Timing
Is now a good time?
Considers earnings proximity,
Slope -4.6% — flat/unclear
IV percentile 50% — neutral
IV kink -5.3pts — no clear event
θ/ν ratio 1.00 — favors mixed
3 liquid expirations — flexible
safe window: No earnings detected
Spread ratio 1.00x — stable
Flow +10% @ 55% consistency — unclear
Score 83 (ITM 20% + inst 53%) — HIGH institutional
Directional Strategy Fit
For educational purposes only. Not investment advice.